![](/img/cover-not-exists.png)
A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer
E. Eisenhauer, V. Zanagnolo, D. Cohn, R. Salani, D. O'Malley, G. Sutton, B. Cobb, M. Vaughan, J. Fowler, L. CopelandVolume:
120
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.ygyno.2010.12.076
File:
PDF, 134 KB
english, 2011